Walgreen Co. has named Mark Lelinski corporate vice president of market access.


Walgreens, Mark Lelinski, corporate vice president of market access, Kermit Crawford, pharmacy, pricing strategies, market access group, AstraZeneca, Accenture






























































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Inside This Issue - News

Walgreens tabs Lelinski as VP of market access

August 5th, 2013

DEERFIELD, Ill. – Walgreen Co. has named Mark Lelinski corporate vice president of market access.

Lelinski is responsible for contracting and pricing strategies and integration efforts across Walgreens’ pharmacy, health and wellness division; sales and account management; and overseeing the continued evolution of the company’s managed market strategies.

“Mark is a seasoned leader with an established track rec­ord of delivering results, and will help to build upon the excellent work that is being done in our market access group,” said Kermit Crawford, Walgreens’ president of pharmacy, health and wellness. “His experience in managed market roles both in the U.S. and internationally is the right fit for where Walgreens is headed.

“As a strategic partner of choice in the health care industry, we believe Mark’s relationship-driven approach will help us strengthen our partnerships and create more value from the emerging models and markets that will be key to our growth moving forward.”

Lelinski previously spent nine years with AstraZeneca PLC in several marketing, strategy and managed market roles in the United States and abroad.

In his most recent role as vice president of marketing and sales for the Americas region, Lelinski was responsible for implementing new commercial capabilities across markets in the United States, Canada and Latin America. He also led efforts to build new capabilities in Latin America to improve market access and patient affordability for the emerging middle class. As vice president of U.S. managed markets, Lelinski led all aspects of payer strategy, business-to-business marketing, account management, contracting and pricing with all payer customers.

Before joining AstraZeneca, Lelinski was a partner at Accenture, where he headed the pharmaceutical marketing and sales effectiveness practice. He also worked in a number of executive roles supporting physician networks, health plans and health informatics companies.

Advertisement